|Attending the GACD meeting were (from l) Dr. Lixin Jiang, Chinese Academy of Medical Sciences; Dr. Roger Glass, director, Fogarty International Center; Dr. Guillermo Ruiz Palacios, National Institutes of Health in Mexico; Ambassador Eric Goosby; Dr. Alain Beaudet, Canadian Institutes of Health Research; Dr. Karim Berkouk, European Commission; Dr. Xuetao Cao, Chinese Academy of Medical Sciences; Prof. Warwick Anderson, Australia National Health and Medical Research Council; and Celina Gorre, GACD.
In June, the Global Alliance for Chronic Diseases (GACD) and representatives from NIH hosted an event at the United States Capitol Visitor Center with Ambassador Eric Goosby, the U.S. global AIDS coordinator and head of the Office of Global Health Diplomacy at the U.S. Department of State.
During the event, Goosby and members of the GACD board participated in a panel discussion that was moderated by Dr. Roger Glass, director of the Fogarty International Center and NIH associate director for international research. The discussion highlighted strategic investments in global health research with a particular focus on chronic, noncommunicable diseases (NCDs) in low- and middle-income countries.
NCDs, which account for around 60 percent of all deaths globally, transcend borders and countries, which is why it’s critical to take a global and collaborative approach to addressing them. As Goosby indicated, it makes sense to expand the United States’ work in the global health space to include NCDs, as they affect so many people around the world. There is a lot that can be done by combining efforts on an international scale.
NIH is a founding member of GACD, which is composed of public research funding agencies from Australia, Canada, China, the EU, India, South Africa, the United Kingdom and the U.S. GACD is the first collaboration of major international public research funding agencies to specifically address chronic NCDs.